Ribobay Pharma, a prominent Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO), in conjuncti...
Biopharmaceutical contract manufacturer SK pharmteco commits to production, testing, and release of Ferring’s U.S. approved ADSTILADRIN® ...
CordenPharma, a global CDMO leader in the manufacturing of Drug Substance (APIs) complex modalities (such as peptides, oligos and lipids) and injectable Dr...
FibroBiologics, , a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential...
The facilities, located in Solna, Stängnäs, Höganäs, Karlskoga, and Uppsala OTC Development in Sweden, Pessac in France...
Bora Pharmaceuticals Co., Ltd. announced that it has completed the acquisition of Upsher-Smith Laboratories, LLC. (“Upsher-Smith”),...
SCHOTT Pharma announces plans to solidify its footprint in the United States with the establishment of a cutting-edge facility in Wilson, Nor...
One of the notable achievements in fiscal 2023 was Catalent's robust efforts to mitigate its environmental impact and combat climate ...
Hovione has entered into a license agreement with Dragonfly Technologies, Inc. to offer its customers the breakthrough micellar technology developed by...
This strategic acquisition marks a pivotal step towards creating a combined entity with expanded capabilities and a robust service offering that spans from...
Vetter, a globally recognized contract development and manufacturing organization (CDMO), proudly announces the successful market introduction of eight cus...
In a landmark move within the life sciences sector, Novo Holdings has announced its acquisition of Catalent, Inc. in an all-cash transaction valued at $16....
In a bold move, Ricks emphasized the urgency for financial regulators to scrutinize the deal, pointing out Catalent's extensive client base, compri...
In a strategic shift that promises to redefine the pharmaceutical industry, Novo Holdings, the investment arm of Novo Nordisk's parent foundation, has unve...
© 2024 Biopharma Boardroom. All Rights Reserved.
